Related Experiment Video

Updated: May 19, 2026

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

The role of S6K1 in ER-positive breast cancer

Marina K Holz1

  • 1Department of Biology, Stern College for Women of Yeshiva University, New York, NY, USA. mholz@yu.edu

Cell Cycle (Georgetown, Tex.)
|August 17, 2012
PubMed

Insights

The 40S ribosomal S6 kinase 1 (S6K1) is a key regulator of cell growth and proliferation. Its hyperactivation in ER-positive breast cancer suggests S6K1 as a potential prognostic marker and therapeutic target.

Area of Science:

  • Molecular Biology
  • Cellular Signaling
  • Oncology

Background:

  • The 40S ribosomal S6 kinase 1 (S6K1) is a serine/threonine protein kinase and a downstream effector of the mammalian target of rapamycin complex 1 (mTORC1).
  • S6K1 integrates signals from growth factors, amino acids, energy status, and hypoxia.
  • It regulates critical cellular processes including growth, proliferation, survival, apoptosis, migration, and invasion.

Purpose of the Study:

  • To investigate the role of S6K1 in estrogen receptor (ER)-positive breast cancer.
  • To explore the potential of S6K1 as a prognostic marker and therapeutic target in this cancer type.

Main Methods:

  • Analysis of S6K1's role in oncogenic processes.
  • Investigation of S6K1's interaction with estrogen receptor alpha (ERα).
  • Assessment of S6K1 expression regulation by estrogen.

Main Results:

  • S6K1 directly phosphorylates and activates ERα.
  • S6K1 expression is regulated by estrogen.
  • Hyperactivation of mTORC1/S6K1 signaling correlates with ER-positive breast cancer status.

Conclusions:

  • S6K1 plays a significant role in ER-positive breast cancer.
  • Hyperactivated mTORC1/S6K1 signaling may serve as a prognostic marker.
  • S6K1 represents a potential therapeutic target for ER-positive breast cancer.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...